Phospho-ILK (S246) Polyclonal Antibody, 100µg, (ATB-P1044)
$238.00
- Description
- Size Guide
- Reviews (0)
Description
Background:
This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Receptor-proximal protein kinase regulating integrin-mediated signal transduction. May act as a mediator of inside-out integrin signaling. Focal adhesion protein part of the complex ILK-PINCH. This complex is considered to be one of the convergence points of integrin- and growth factor-signaling pathway. Could be implicated in mediating cell architecture, adhesion to integrin substrates and anchorage-dependent growth in epithelial cells. Phosphorylates beta-1 and beta-3 integrin subunit on serine and threonine residues, but also AKT1 and GSK3B.
Product datasheet:
Overview | |
| Product Description | Phospho-ILK (S246) Polyclonal Antibody, 100µg, (ATB-P1044) |
| Species Reactivities | Human,Mouse,Rat |
| Immunogen | Synthesized peptide derived from human ILK around the phosphorylation site of S246. |
Properties | |
| Form | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage Instructions | -20°C/1 year |
| Clonality | Polyclonal |
References:
- Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling. Yan Z, et al. Acta Histochem, 2014 Apr. PMID 24360977
- The integrin-linked kinase gene up-regulated by hypoxia plays its pro-survival role in colorectal cancer cells. Xiao L, et al. J Recept Signal Transduct Res, 2014 Feb. PMID 24299190
- ILK: a pseudokinase with a unique function in the integrin-actin linkage. Ghatak S, et al. Biochem Soc Trans, 2013 Aug. PMID 23863169
- Overexpression of ILK1 in breast cancer associates with poor prognosis. Yang HJ, et al. Tumour Biol, 2013 Dec. PMID 23832543
- Role of integrin-linked kinase in osteosarcoma progression. Rhee SH, et al. J Orthop Res, 2013 Oct. PMID 23784942
- Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase.
Hannigan G.E., Leung-Hagesteijn C., Fitz-Gibbon L., Coppolino M.G., Radeva G., Filmus J., Bell J.C., Dedhar S.
Nature 379:91-96(1996) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Placenta. - Cloning of an isoform of integrin-linked kinase (ILK) that is upregulated in HT-144 melanoma cells following TGF-beta1 stimulation.
Janji B., Melchior C., Vallar L., Kieffer N.
Oncogene 19:3069-3077(2000) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). - Integrin-linked kinase genomic sequence.
Tadic B., Hannigan G.E.
Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. - Structural organisation of the gene encoding integrin-linked kinase 1.
Melchior C., Janji B., Kreis S., Kieffer N.
Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. - Complete sequencing and characterization of 21,243 full-length human cDNAs.
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3). Tissue: Cerebellum and Colon.


| size | chest(in.) | waist(in.) | hips(in.) |
|---|---|---|---|
| XS | 34-36 | 27-29 | 34.5-36.5 |
| S | 36-38 | 29-31 | 36.5-38.5 |
| M | 38-40 | 31-33 | 38.5-40.5 |
| L | 40-42 | 33-36 | 40.5-43.5 |
| XL | 42-45 | 36-40 | 43.5-47.5 |
| XXL | 45-48 | 40-44 | 47.5-51.5 |




Reviews
There are no reviews yet.